List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 280 studies with search of: Arnold-Chiari Malformation
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
Condition: Alzheimer's Disease
Interventions: Drug: rivastigmine transdermal patch 15 cm2;   Drug: rivastigmine transdermal patch 5 cm2
2 Completed Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Condition: Hypogonadism
Interventions: Drug: 28 cm2 matrix testosterone system;   Drug: 48 cm2 testosterone matrix system;   Drug: one 24 cm2 and one 48 cm2 testosterone matrix system
3 Completed Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
Condition: Actinic Keratosis
Intervention: Drug: PEP005 Topical gel
4 Completed Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne
Condition: Acne
Intervention: Drug: MAL
5 Not yet recruiting Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia
Conditions: Keratoconus;   Corneal Ectasia
Interventions: Procedure: Corneal collagen cross-linking for 3 minutes at 30 mW/cm2;   Drug: riboflavin ophthalmic solution;   Procedure: Corneal collagen cross-linking for 3 minutes at 45 mW/cm2
6 Enrolling by invitation A 24 Week Open-Label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch 15 cm2
7 Completed
Has Results 		Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years
Condition: Barrett Esophagus
Intervention: Device: HALO Ablation System
8 Completed Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Condition: Healthy
Intervention: Drug: testosterone
9 Completed Duragen Versus Duraguard in Chiari Surgery
Condition: Chiari Malformation
Interventions: Procedure: Duraplasty with Duragen;   Procedure: Duraplasty with Duraguard
10 Completed Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
Condition: Actinic Keratoses
Intervention: Drug: PEP005
11 Recruiting Genetic Analysis of the Chiari I Malformation
Conditions: Syringomyelia;   Type I Arnold Chiari Malformation
Intervention:
12 Enrolling by invitation Chiari Study Looking at Use of Duragen Versus Duraguard
Condition: Chiari Malformation Type I
Intervention:
13 Recruiting Assessment of Efficacy and Safety of 3 Different Doses of co.Don Chondrosphere to Treat Large Cartilage Defects
Conditions: Large Articular Cartilage Lesions of the Femoral;   Condyle, Trochlea, Tibia or Retropatellar
Intervention: Drug: co.don chondrosphere®
14 Completed Establishing the Physiology of Syringomyelia
Conditions: Arnold Chiari Deformity;   Hydrocephalus;   Syringomyelia
Intervention:
15 Recruiting Evaluation of Safety and Efficacy of ATX-101 in the Reduction of Submental Fat
Condition: Healthy
Interventions: Drug: ATX-101;   Drug: Placebo
16 Recruiting Evaluation of Safety and Efficacy of ATX-101 in the Reduction of Submental Fat
Condition: Healthy
Interventions: Drug: ATX-101;   Drug: Placebo
17 Unknown † Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-Dependent Diabetes Mellitus (IDDM)
Conditions: Diabetes Mellitus, Type 1;   Diabetic Retinopathy
Intervention: Procedure: Light will be switched from 0.5µW/cm2/sr to 115µW/cm2/sr.
18 Completed A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Condition: Actinic Keratoses
Intervention: Drug: PEP005
19 Completed The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
Conditions: Parkinsons Disease With Dementia;   Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
Intervention: Drug: Rivastigmine Patch 9.5 cm2
20 Completed Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Condition: Alzheimer Disease
Intervention: Drug: Rivastigmine transdermal patch

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services